CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 08, 2022 (GLOBE NEWSWIRE – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, …
CENTOGENE Announces Nomination of Andreas Busch to Supervisory Board
Nomination adds significant expertise to support pharma partnerships and an impressive track record in value creation CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE …
CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan
Enables refocusing on core business of delivering valuable, data-driven insights to patients, and pharmaceutical companies globally EUR 15 million private placement from leading growth investors and …
CENTOGENE Announces Nomination of Kim Stratton as Chief Executive Officer
Dr. Andrin Oswald resigns as CEO due to prolonged medical leave; Kim Stratton elected as successor CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE NEWSWIRE – Centogene …
CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
Combining Expertise to Advance Precision Medicine, While Enabling a More Efficient and Timely Diagnosis of Rare Diseases Around the World CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN and SOUTH …
CENTOGENE Announces Leadership Transition
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 20, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world …
CENTOGENE Announces Pricing of Primary and Secondary Public Offering of Common Shares
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 9, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“Centogene” or the “Company”), a commercial-stage company focused on rare diseases …
CENTOGENE Announces Proposed Primary and Secondary Public Offering of Common Shares
July 7, 2020 at 6:16 PM EDT CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases …
Centogene öffnet seine Labore für Coronatests
Verantwortung in Krisenzeiten: Ein Rostocker Unternehmen, das sonst seltenen Krankheiten auf der Spur ist, öffnet seine Labore für lebensrettende Coronatests. Bis zu 10.000 Abstriche können pro Tag …
Centogene Announces Commencement of Testing for COVID-19
Cambridge, MA, USA & Rostock/Berlin, Germany, March 18, 2020 (GLOBAL NEWSWIRE) – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical …